No man in the world has more courage than the man who can stop after eating one peanut.

Channing Pollock

Who is obese

Fat distribution can influence a person's risk of disease. Fat carried around the waist and in the abdominal area, characterized by the "apple shape", is associated with an increased risk for many medical problems such as heart disease, cancer, high blood pressure, and diabetes. Fat that is mostly distributed around the buttocks and thighs is associated with a lower risk of developing these diseases.

As much as 50 to 75 percent of obesity has genetic influences. Just what those genetic influences are that affect body weight have not been identified.

Research points to differences in appetite control and energy expenditure. It is important for obese people not to hold themselves responsible for their condition.

Many people are tempted by ads that use celebrities to tout liquid fasting diets for weight loss. Ads claim quick and easy weight loss with use of such products. Very obese patients may be referred to these types of diets. Their diets are carefully supervised by their healthcare provider.

Fasting diets for weight loss may be right for obese persons who have serious weight-related medical problems. Rapid weight loss is the primary advantage of using these diets. This may be helpful in motivating the individual to continue with the program. This may help to support lifestyle changes which are needed for continued weight loss.

Proper use of these diets requires close monitoring and follow-up. To promote lasting weight loss, lifestyle changes must be made by the dieter while on the fast.

Bulimia nervosa is an eating disorder that is estimated to be present in up to 5 percent of teenage and young adult women. It is characterized by binge eating followed by purging and other behaviors such as vomiting. Laxatives, diet pills, water pills, exercise or fasting may also be used.

Overweight vs. overfat

Knowing your body composition can help you design a fitness program to build more fat-burning muscle. Resolving to change your body composition and not simply to lose weight, can improve your overall health.

The risk of developing weight associated medical problems increases if the majority of body fat is located in the abdominal area. This risk decreases if body fat is primarily located in the hips, buttock and thigh region.

Height and weight tables are generally used to determine how person's weight compares to a standard. However, weight in these tables is an overall measure of all components of the body. Individuals may differ in muscle, frame size and percentage of body fat. The waist to hip ratio of body composition assessment provides information on where the majority of body fat is located.

Appetite suppressant drugs

Obesity is a chronic disease that affects many people and often requires long-term treatment to promote and sustain weight loss. As in other chronic conditions, such as diabetes or high blood pressure, long-term use of prescription medications may be appropriate for some individuals

The medications most often used in the management of obesity are commonly known as "appetite suppressant" medications. Appetite suppressant medications promote weight loss by increasing metabolism and by decreasing appetite or increasing the feeling of being full. These medications work by increasing the serotonin and/or catecholamine - two brain chemicals that affect mood, appetite and metabolism.

Appetite suppressant medications help weight loss by diminishing appetite or increasing the feeling of being full. These medications diminish appetite by rising serotonin or catecholamine two brain chemicals that affect appetite. Appetite suppressant medications are used with a course of behavioral treatment and dietary counseling, designed to help you make long-term changes in your diet and physical activity.

While the FDA regulates how a medication can be advertised or promoted by the manufacturer, these regulations do not restrict a doctor's ability to prescribe the medication for different conditions, in different doses, or for different lengths of time.

Maximum weight loss usually occurs within six months of starting medication treatment. Weight tends to level off or increase during the remainder of treatment. Studies suggest that if a patient does not lose at least four pounds over four weeks on a particular medication, then that medication is unlikely to help the patient achieve significant weight loss.

When considering long-term appetite suppressant medication treatment for obesity, you should consider the following areas of concern and potential risks. Currently, all prescription medications to treat obesity are controlled substances, meaning doctors need to follow certain restrictions when prescribing appetite suppressant medications. Although abuse and dependence are not common with non-amphetamine appetite suppressant medications, doctors should be cautious when they prescribe these medications for patients with a history of alcohol or other drug abuse.

Most studies of appetite suppressant medications show that a patient's weight tends to level off after four to six months while still on medication treatment. While some patients and physicians may be concerned that this shows tolerance to the medications, the leveling off may mean that the medication has reached its limit of effectiveness. Based on the currently available studies, it is not clear if weight gain with continuing treatment is due to drug tolerance.

However obesity, is more appropriately considered a chronic disease than a lifestyle choice. Other chronic diseases, such as diabetes, and high blood pressure, are managed by long-term drug treatment, even though these diseases also improve with changes in lifestyle, such as diet and exercise. Although this issue may concern physicians and patients, social views on obesity should not prevent patients from seeking medical treatment to prevent health risks that can cause serious illness and death.

Terms and definitions on this page

FDA

• Food and Drug Administration: A government agency that oversees public safety in relation to drugs and medical devices. The FDA gives approval to pharmaceutical companies for commercial marketing of their products.

Fat blocker

• Drugs that block the absorption of fat or calories, and lose substantial weight.

Overweight

• Weighing more than is normal, necessary, or allowed, especially having more body weight than is considered normal or healthy for one's age or build.

Appetite

• An instinctive physical desire, especially one for food or drink. Decreased desire to eat is termed anorexia, while polyphagia (or "hyperphagia") is increased eating. Disregulation of appetite contributes to anorexia nervosa and cachexia, or oppositely, overeating.

Diabetes

• Any of several metabolic disorders marked by excessive discharge of urine and persistent thirst, especially one of the two types of diabetes mellitus.

Diet

• A regulated selection of foods, as for medical reasons or cosmetic weight loss.


• A solutions designed to reduce or suppress the appetite.

Fat

• Any of various soft, solid, or semisolid organic compounds constituting the esters of glycerol and fatty acids and their associated organic groups.

Obesity

• The condition of being obese; increased body weight caused by excessive accumulation of fat.

Stress

• A state of extreme difficulty, pressure, or strain.


• A physical and psychological response that results from being exposed to a demand or pressure.

Suppress

• To curtail or prohibit the activities of.


• To inhibit the expression of (an impulse, for example).


• To bring to an end forcibly as if by imposing a heavy weight.

Recovery and rejuvenation at european beauty clinic